EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals

Takayuki Iwamoto, Yasutoshi Nozaki, Takanori Inoue, Takahiro Suda, Rui Mizumoto, Yuki Arimoto, Takashi Ohta, Shinjiro Yamaguchi, Yoshiki Ito, Yoshiko Sudo, Michiko Yoshimura, Machiko Kai und 5 weitere

Journal of Gastroenterology · 2025-02 · 60 (2) · 197-209

DOI: 10.1007/s00535-024-02165-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 25.11.2024. Verfasst von Takayuki Iwamoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki, Hyogo, 660-8511, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, Liver Cirrhosis, Hepatitis C, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The histological improvement in liver fibrosis in patients with hepatitis C who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) treatment has not been comprehensively investigated. Therefore, we assessed the histological changes in liver fibrosis among patients with hepatitis C who underwent long-term follow-up after achieving SVR to treatment with DAA.

Methods

This retrospective study enrolled 71 patients with hepatitis C who achieved SVR to treatment with DAA. Changes in histological liver fibrosis and fibrosis biomarkers (hyaluronic acid, type 4 collagen 7S, Mac-2 binding protein glycosylation isomer, autotaxin, and Fibrosis-4 index) were assessed before and 5 years after treatment. Transient elastography using the FibroScan® device was performed 5 years after treatment. Advanced fibrosis and cirrhosis were defined as Ishak fibrosis scores of ≥ 4 and ≥ 5, respectively.

Results

Histological liver fibrosis significantly regressed after SVR. Fibrosis biomarkers were significantly reduced after SVR. Transient elastography was the most helpful after evaluating the predictive performance of advanced fibrosis and cirrhosis after SVR, with an area under the receiver operating characteristic curve of 0.965 and a cut-off value of 6.75 kPa. The cut-off values of serum fibrosis biomarkers for identifying advanced fibrosis and cirrhosis after SVR were lower than those before treatment.

Conclusions

Long-term SVR to treatment with DAA ameliorated histological liver fibrosis. Noninvasive tests helped predict the degree of liver fibrosis after SVR, but their cut-off values should be redefined to avoid underestimation of liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsLiver CirrhosisHepatitis C, ChronicHumansMaleFemaleMiddle AgedRetrospective StudiesElasticity Imaging TechniquesSustained Virologic ResponseBiomarkersAgedFollow-Up StudiesAdultTreatment OutcomeHyaluronic Acid

Stichwörter der Autor:innen

Direct-acting antiviralHepatitis C virusLiver fibrosisSustained virological response

Substanzen

Antiviral AgentsBiomarkersHyaluronic Acid

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki, Hyogo, 660-8511, Japan.
  • Department of Diagnostic Pathology, Kansai Rosai Hospital, Hyogo, Japan.
  • Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki, Hyogo, 660-8511, Japan. hagiwara-hideki@kansaih.johas.go.jp.

ORCID-Profile: Hideki Hagiwara

Zitieren

APA

Iwamoto, T., Nozaki, Y., Inoue, T., Suda, T., Mizumoto, R., Arimoto, Y., Ohta, T., Yamaguchi, S., Ito, Y., Sudo, Y., Yoshimura, M., Kai, M., Sasaki, Y., Tahata, Y., Hikita, H., Takehara, T., & Hagiwara, H. (2025). Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals. Journal of Gastroenterology, 60(2), 197-209. https://doi.org/10.1007/s00535-024-02165-0

Vancouver

Iwamoto T, Nozaki Y, Inoue T, Suda T, Mizumoto R, Arimoto Y, et al. Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals. Journal of Gastroenterology. 2025;60(2):197-209. doi:10.1007/s00535-024-02165-0

BibTeX
@article{Iwamoto2025,
  author = {Iwamoto, Takayuki and Nozaki, Yasutoshi and Inoue, Takanori and Suda, Takahiro and Mizumoto, Rui and Arimoto, Yuki and Ohta, Takashi and Yamaguchi, Shinjiro and Ito, Yoshiki and Sudo, Yoshiko and Yoshimura, Michiko and Kai, Machiko and Sasaki, Yoichi and Tahata, Yuki and Hikita, Hayato and Takehara, Tetsuo and Hagiwara, Hideki},
  title = {Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals},
  journal = {Journal of Gastroenterology},
  year = {2025},
  volume = {60},
  number = {2},
  pages = {197--209},
  doi = {10.1007/s00535-024-02165-0}
}
Kostenlos starten →